118 related articles for article (PubMed ID: 24346538)
1. Will the promise of drug-induced therapeutic hypothermia be fulfilled?
Mulder M; Geocadin RG
Crit Care Med; 2014 Jan; 42(1):221-3. PubMed ID: 24346538
[No Abstract] [Full Text] [Related]
2. Improved cardiac and neurologic outcomes with postresuscitation infusion of cannabinoid receptor agonist WIN55, 212-2 depend on hypothermia in a rat model of cardiac arrest.
Ma L; Lu X; Xu J; Sun S; Tang W
Crit Care Med; 2014 Jan; 42(1):e42-8. PubMed ID: 24346544
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids after cardiac arrest: should your brain be on drugs?
Tisherman SA
Crit Care Med; 2010 Dec; 38(12):2409-10. PubMed ID: 21088506
[No Abstract] [Full Text] [Related]
4. Pharmacologically induced hypothermia with cannabinoid receptor agonist WIN55, 212-2 after cardiopulmonary resuscitation.
Sun S; Tang W; Song F; Chung SP; Weng Y; Yu T; Weil MH
Crit Care Med; 2010 Dec; 38(12):2282-6. PubMed ID: 20890199
[TBL] [Abstract][Full Text] [Related]
5. Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Wlaz A; Karwan S; Florek-Luszczki M; Czuczwar SJ
Eur J Pharmacol; 2013 Nov; 720(1-3):247-54. PubMed ID: 24161913
[TBL] [Abstract][Full Text] [Related]
6. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
7. Δ
Darmani NA; Belkacemi L; Zhong W
Eur J Pharmacol; 2019 Dec; 865():172806. PubMed ID: 31738934
[TBL] [Abstract][Full Text] [Related]
8. Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice.
Luszczki JJ; Andres-Mach M; Barcicka-Klosowska B; Florek-Luszczki M; Haratym-Maj A; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1870-6. PubMed ID: 21777642
[TBL] [Abstract][Full Text] [Related]
9. The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling.
Wang DP; Lv QL; Lin Q; Kang K; Jin KY; Hai J
Neurotox Res; 2020 Apr; 37(4):847-856. PubMed ID: 31808139
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid 1 (CB1) receptor mediates WIN55, 212-2 induced hypothermia and improved survival in a rat post-cardiac arrest model.
Weng Y; Sun S; Park J; Ye S; Weil MH; Tang W
Resuscitation; 2012 Sep; 83(9):1145-51. PubMed ID: 22289684
[TBL] [Abstract][Full Text] [Related]
11. Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs.
Fries M; Brücken A; Çizen A; Westerkamp M; Löwer C; Deike-Glindemann J; Schnorrenberger NK; Rex S; Coburn M; Nolte KW; Weis J; Rossaint R; Derwall M
Crit Care Med; 2012 Apr; 40(4):1297-303. PubMed ID: 22425822
[TBL] [Abstract][Full Text] [Related]
12. The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia.
Wang DP; Yin H; Kang K; Lin Q; Su SH; Hai J
Psychiatry Res; 2018 Sep; 267():281-288. PubMed ID: 29945070
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
14. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
15. Targeting glial cannabinoid CB
Espejo-Porras F; García-Toscano L; Rodríguez-Cueto C; Santos-García I; de Lago E; Fernandez-Ruiz J
Br J Pharmacol; 2019 May; 176(10):1585-1600. PubMed ID: 29574689
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
Su SH; Wu YF; Lin Q; Hai J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1189-1200. PubMed ID: 28825114
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic effect of WIN 55,212-2, a cannabinoid agonist, in a murine xenograft model of gastric cancer.
Oh JH; Lee JY; Baeg MK; Han KH; Choi MG; Park JM
Chemotherapy; 2013; 59(3):200-6. PubMed ID: 24335109
[TBL] [Abstract][Full Text] [Related]
18. Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Florek-Luszczki M; Wlaz A; Zagaja M; Andres-Mach M; Kondrat-Wrobel MW; Luszczki JJ
Pharmacol Biochem Behav; 2015 Mar; 130():53-8. PubMed ID: 25592741
[TBL] [Abstract][Full Text] [Related]
19. [Mild therapeutic hypothermia after cardiopulmonary resuscitation - no].
Klein H
Dtsch Med Wochenschr; 2015 Jan; 140(1):59. PubMed ID: 25580977
[No Abstract] [Full Text] [Related]
20. [Mild therapeutic hypothermia after cardiopulmonary resuscitation - yes].
Arntz HR
Dtsch Med Wochenschr; 2015 Jan; 140(1):58. PubMed ID: 25580976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
